Such knowledge could have an impact on the prediction of early cancer development, and therefore, be used to advise the timing of preventive therapies, and targeted therapies of BRCA2 related breast cancer in the future as discussed here above. This evidence concerns the gene BRCA2 and breast carcinoma.